Vital Signsby BridgeheadAll voices

01  Voice · Academic · Respiratory (asthma/COPD)

Susanne Stowasser: no photograph is held, so the academic plate is shown instead.
Academic

Susanne Stowasser

MD, head of clinical development pulmonology/rheumatology at Boehringer Ingelheim International GmbH

Press citations per month · linked articles
1
0
Oct 2026Nov 2026to date
1

press citation on 1 topic since 1 Oct 2026 · last quoted 1 Oct 2026

02  Quoted on · 1 of 29 topics

Open the topic

Susanne Stowasser: key facts

Kind of voice
Academic
Role
MD, head of clinical development pulmonology/rheumatology at Boehringer Ingelheim International GmbH
Tracked press citations
1
Most recently quoted
1 Oct 2026

04  On the record · press

What Susanne Stowasser has said

By outlet · linked articles
  • scientistlive.com1

Verbatim

“The INBUILD trial has provided important insights into the treatment of patients with progressive pulmonary fibrosis, and these new analyses demonstrate the potential value of quantitative CT as an additional measure of disease progression and treatment response. The ability to detect meaningful changes in lung structure alongside established clinical measures could help strengthen the evidence base for antifibrotic therapies and inform the design of future clinical trials.”
MD, head of clinical development pulmonology/rheumatology at Boehringer Ingelheim International GmbH · Respiratory (asthma/COPD) · scientistlive.com · 1 Oct 2026 · Read the article

Related media coverage

Recent UK press coverage of their topics, not necessarily citing them directly.

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.